VNRX (VolitionRX) Cyclically Adjusted FCF per Share: $-8.64 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VNRX VolitionRX Ltd VNRX
54 GF Score
Price $0.58
GF Value $17.52
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is VolitionRX Cyclically Adjusted FCF per Share?

VolitionRX VNRX +71.82% 54 Cyclically Adjusted FCF per Share is $-8.64 as of Jun. 2026. GuruFocus rates VNRX with a GF Score™ of 54/100 and a GF Value™ of $17.52 (Possible Value Trap). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

VolitionRX's adjusted free cash flow per share for the three months ended in Jun. 2026 was $-0.564. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-8.64 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 1.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -2.70% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was -12.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of VolitionRX was 1.90% per year. The lowest was -34.00% per year. And the median was -14.10% per year.

As of today (2026-08-27), VolitionRX's current stock price is $0.5828. VolitionRX's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was $-8.64. VolitionRX's Cyclically Adjusted Price-to-FCF of today is .


VolitionRX  (AMEX:VNRX) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


VolitionRX Cyclically Adjusted FCF per Share Related Terms


VolitionRX Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for VolitionRX's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VolitionRX Cyclically Adjusted FCF per Share Chart

VolitionRX Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.86 -9.36 -9.53 -9.55 -8.83

VolitionRX Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.30 -9.07 -8.83 -8.77 -8.64

VNRX vs ALRTF, ADGM, NXL: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, VolitionRX's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VolitionRX Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, VolitionRX's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where VolitionRX's Cyclically Adjusted Price-to-FCF falls into.


VNRX
54GF Score
VolitionRX Ltd VNRX
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

VolitionRX Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, VolitionRX's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.564/333.9520*333.9520
=-0.564

Current CPI (Jun. 2026) = 333.9520.

VolitionRX Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 -1.798 241.428 -2.487
201612 -1.688 241.432 -2.335
201703 -2.714 243.801 -3.718
201706 -2.406 244.955 -3.280
201709 -2.208 246.819 -2.987
201712 -2.995 246.524 -4.057
201803 -2.618 249.554 -3.503
201806 -2.031 251.989 -2.692
201809 -2.846 252.439 -3.765
201812 -2.121 251.233 -2.819
201903 -2.078 254.202 -2.730
201906 -1.491 256.143 -1.944
201909 -1.926 256.759 -2.505
201912 -1.338 256.974 -1.739
202003 -2.490 258.115 -3.222
202006 -2.164 257.797 -2.803
202009 -1.949 260.280 -2.501
202012 -1.642 260.474 -2.105
202103 -2.612 264.877 -3.293
202106 -2.123 271.696 -2.609
202109 -1.889 274.310 -2.300
202112 -1.695 278.802 -2.030
202203 1.296 287.504 1.505
202206 -2.529 296.311 -2.850
202209 -2.546 296.808 -2.865
202212 -2.217 296.797 -2.495
202303 -2.973 301.836 -3.289
202306 -2.287 305.109 -2.503
202309 -2.223 307.789 -2.412
202312 1.545 306.746 1.682
202403 -2.055 312.332 -2.197
202406 -1.668 314.175 -1.773
202409 -1.257 315.301 -1.331
202412 -1.203 315.605 -1.273
202503 -0.891 319.799 -0.930
202506 -1.235 322.561 -1.279
202509 -0.671 324.800 -0.690
202512 -0.910 324.054 -0.938
202603 -0.768 330.213 -0.777
202606 -0.564 333.952 -0.564

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-8.64 mean?
VolitionRX (VNRX) has a Cyclically Adjusted FCF per Share of $-8.64 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on VolitionRX and its competitors.
Is VolitionRX's Cyclically Adjusted FCF per Share too high?
VolitionRX's current Cyclically Adjusted FCF per Share is $-8.64. Overall, VolitionRX has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does VolitionRX's Cyclically Adjusted FCF per Share compare to ALRTF and ADGM?
VolitionRX's Cyclically Adjusted FCF per Share of $-8.64 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on VolitionRX and its competitors. VolitionRX's current Cyclically Adjusted FCF per Share is $-8.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VolitionRX stock overvalued right now?
Based on GuruFocus' analysis, VolitionRX (VNRX) is currently considered Possible Value Trap. The stock's GF Value™ is $17.52, compared to a current price of $0.58 — trading 96.7% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $-8.64. VolitionRX's overall GF Score™ is 54/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For VolitionRX (VNRX), the current Cyclically Adjusted FCF per Share is $-8.64 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is VolitionRX (VNRX) Overvalued in 2026?

Based on GuruFocus' analysis, VolitionRX stock appears to be undervalued. The current stock price of $0.58 is trading 96.7% below its estimated GF Value™ of $17.52. GuruFocus considers VolitionRX to be Possible Value Trap.

Key valuation signals for VNRX:

  • Cyclically Adjusted FCF per Share: $-8.64
  • GF Value™: $17.52 vs. price of $0.58 (96.7% below fair value)
  • GF Score™: 54/100 with 8 warning signs

No single metric tells the full story. See the VNRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


VolitionRX Business Description

Address 1489 West Warm Springs Road, Suite 110, Henderson, NV, USA, 89014
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.
54GF Score

Get the complete analysis for VNRX

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.58
Price
$17.52
GF Value